HY10275 is a novel compound specifically designed to modulate two key neurobiological mechanisms that interfere with the sleeping process. HY10275 is highly selective for histamine H1 and serotonin 5HT2a, two... HY10275 is highly selective for histamine H1 and serotonin 5HT2a, two chemical receptors that are known to impact the ability to fall asleep and stay asleep.
- Mechanism
- Curator reviewed
HY10275 is specifically designed to modulate two key neurobiological mechanisms that interfere with the sleeping process. The drug is highly selective for histamine H1 and serotonin 5HT2a, two chemical receptors that are known to impact the ability to fall asleep and stay asleep. This dual-acting receptor activity and the lack of affinity for undesired off-target receptors are thought to account for the compounds excellent efficacy and tolerability profile.
- Primary indication
- Investigated for use/treatment in insomnia.Curator reviewed
- Code names
- HY10275
Resolves to
What you can answer from here — as of April 02, 2025
Which drugs share a target with HY10275, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account